Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$9.02 - $12.93 $808,498 - $1.16 Million
-89,634 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$10.56 - $13.94 $85,282 - $112,579
8,076 Added 9.9%
89,634 $1.09 Million
Q4 2020

Feb 16, 2021

BUY
$9.44 - $13.3 $332,911 - $469,037
35,266 Added 76.18%
81,558 $879,000
Q3 2020

Nov 10, 2020

BUY
$9.3 - $25.16 $74,362 - $201,179
7,996 Added 20.88%
46,292 $438,000
Q2 2020

Aug 14, 2020

BUY
$15.99 - $22.88 $178,848 - $255,912
11,185 Added 41.26%
38,296 $876,000
Q1 2020

May 11, 2020

BUY
$9.76 - $23.8 $264,603 - $645,241
27,111 New
27,111 $542,000

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $2.98M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.